Why ViaSat Stock Dropped After Earnings

ViaSat shares fell 4.5% after reporting FY Q1 2027 EPS of $0.17 (non-GAAP), nearly double the $0.09 estimate, but revenue missed at $1.16B vs $1.2B consensus (down ~1% YoY). GAAP results showed a net loss of $52M (improved vs -$56M last year) while free cash flow was positive at $72M (+19% YoY) with $1.3B in new orders and a 1.08 book-to-bill. Despite the cash improvement, the article flags valuation concerns—~59x free cash flow and ~86x on enterprise value after $5.2B net debt—leading to a cautious/“sell-like” view at the current price.

Analysis

The market should care less about the headline beat and more about the quality of cash conversion versus the cost of capital. In a levered satellite operator, a few percentage points of revenue disappointment matters because equity value is effectively a call option on future deleveraging; if growth stays flat, FCF can look good for a quarter while the balance sheet still caps upside. The book-to-bill print is supportive near term, but order intake is only useful if it converts into margin-accretive revenue rather than pricing pressure.

The second-order winner set is likely the higher-quality, lower-leverage names in defense comms and satellite bandwidth that can steal budget share if customers prioritize reliability over scale. If VSAT has to defend share with price or incremental customer incentives, that would compress already thin operating leverage and make the equity multiple harder to defend. Credit holders are better insulated than equity here, but a prolonged plateau in revenue growth would keep refinancing optionality expensive and could eventually force asset sales rather than organic de-levering.

Catalyst path: over the next 1-3 months, the key question is whether free cash flow can stay consistently above the mid-$60M quarterly range and whether guidance implies actual top-line reacceleration, not just backlog noise. Over 6-18 months, the real risk is that management uses non-GAAP optics to mask a slow-moving balance-sheet problem; if net debt does not trend lower, the equity rerates down even if FCF is positive. The thesis is falsified if two consecutive quarters show sustained revenue growth, continued positive FCF, and measurable debt reduction.

Contrarianly, the stock could squeeze if investors decide FCF is the only metric that matters and ignore GAAP losses, but that tends to work only when growth is accelerating. Here the setup looks like a quality trap: cash flow is improving faster than the business quality, which usually supports rallies that are better sold than chased.

Key Decisions for Investors

• Short VSAT on any post-print strength over the next 1-2 weeks; use a tight stop if the stock reclaims and holds above the pre-earnings reaction high, because the only credible squeeze catalyst is a sustained FCF re-rating.
• Pair trade: long IRDM / short VSAT for a 1-3 month relative-value expression, betting that the market rewards cleaner recurring revenue and better balance-sheet flexibility over levered cash generation.
• If options liquidity is usable, buy 3-6 month out-of-the-money VSAT put spreads sized for a defined-risk downside view; the trade works best if revenue guidance or margin commentary softens again on the next call.
• Do not add to a short if management prints another quarter of >$60M FCF plus clear net debt reduction; that would invalidate the 'cash flow is temporary' thesis and likely force a cover.
• Watch the defense segment and backlog conversion as a catalyst alert: if defense revenue keeps declining for another quarter, consider increasing short exposure because procurement share loss would be a slower but more durable negative for the equity.